810 related articles for article (PubMed ID: 16266285)
1. Cannabinoids.
Grotenhermen F
Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):507-30. PubMed ID: 16266285
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of cannabinoids.
Grotenhermen F
Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids and the gut: new developments and emerging concepts.
Izzo AA; Sharkey KA
Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids, endocannabinoids, and related analogs in inflammation.
Burstein SH; Zurier RB
AAPS J; 2009 Mar; 11(1):109-19. PubMed ID: 19199042
[TBL] [Abstract][Full Text] [Related]
7. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of cannabinoids.
Grotenhermen F
Clin Pharmacokinet; 2003; 42(4):327-60. PubMed ID: 12648025
[TBL] [Abstract][Full Text] [Related]
9. CB receptor ligands from plants.
Woelkart K; Salo-Ahen OM; Bauer R
Curr Top Med Chem; 2008; 8(3):173-86. PubMed ID: 18289087
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptors and their ligands.
Pertwee RG; Ross RA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
12. Cannabimimetic plants: are they new cannabinoidergic modulators?
Kumar A; Premoli M; Aria F; Bonini SA; Maccarinelli G; Gianoncelli A; Memo M; Mastinu A
Planta; 2019 Jun; 249(6):1681-1694. PubMed ID: 30877436
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor systems: therapeutic targets for tumour intervention.
Jones S; Howl J
Expert Opin Ther Targets; 2003 Dec; 7(6):749-58. PubMed ID: 14640910
[TBL] [Abstract][Full Text] [Related]
14. Plant, synthetic, and endogenous cannabinoids in medicine.
Di Marzo V; Petrocellis LD
Annu Rev Med; 2006; 57():553-74. PubMed ID: 16409166
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid modulation of peripheral autonomic and sensory neurotransmission.
Ralevic V
Eur J Pharmacol; 2003 Jul; 472(1-2):1-21. PubMed ID: 12860468
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?].
Saito VM; Wotjak CT; Moreira FA
Braz J Psychiatry; 2010 May; 32 Suppl 1():S7-14. PubMed ID: 20512266
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development.
Pertwee RG
Expert Opin Investig Drugs; 2000 Jul; 9(7):1553-71. PubMed ID: 11060760
[TBL] [Abstract][Full Text] [Related]
18. [News about therapeutic use of Cannabis and endocannabinoid system].
Duran M; Laporte JR; Capellà D
Med Clin (Barc); 2004 Mar; 122(10):390-8. PubMed ID: 15033046
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids and brain injury: therapeutic implications.
Mechoulam R; Panikashvili D; Shohami E
Trends Mol Med; 2002 Feb; 8(2):58-61. PubMed ID: 11815270
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptors as therapeutic targets.
Mackie K
Annu Rev Pharmacol Toxicol; 2006; 46():101-22. PubMed ID: 16402900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
